A live audio webcast of the presentation will be available under “Events & Presentations” in the News & Events section of the Company’s website at www.primemedicine.com. A replay of the webcast will ...

CBSE Class 12 Chemistry is a crucial subject that requires strong conceptual clarity and regular practice to score well in ...

The CBSE Class 12 Biology exam is scheduled for March 27, 2026. Experts advise students to focus on key topics like Genetics, ...

Mo Khalil is the Hok Lam and Kathleen Kam Wong Professor of Bioengineering and Professor of Molecular and Cellular Biology at the Harvard John A. Paulson School of Engineering and Applied Sciences ...

Dec 15 (Reuters) - Private biotech company Dren Bio has entered into a strategic collaboration with French drugmaker Sanofi (SASY.PA), opens new tab to develop therapies for autoimmune diseases in a ...

A new study published in Addiction has identified genetic factors that influence both a person's risk of developing an addiction and their educational attainment. Researchers found that some genetic ...

A new study has developed a powerful computational method that can detect how genes interact with each other to influence complex traits in humans at a scale previously impossible. The new method was ...

A startup’s ads for controversial embryo tests hit the New York City subway. One day this fall, I watched an electronic sign outside the Broadway-Lafayette subway station in Manhattan switch ...

Securities and Exchange Commission filings indicate that Oxford Finance LLC acquired 1.62 million common shares, representing 16.5% ownership in the clinical-stage company. Oxford Finance, the ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Dec 1 (Reuters) - Belite Bio (BLTE.O), opens new tab said on Monday that its experimental drug for a rare genetic eye disease met the main goal in a late-stage study, sending its shares up over 15% in ...

Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...